NATERA, INC. Cost of Services, Licenses and Services (Deprecated 2018-01-31)
NATERA, INC. (NTRA) reported Cost of Services, Licenses and Services (Deprecated 2018-01-31) of $2.44 million for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServicesLicensesAndServices · last filed 2019-03-15
- NATERA, INC. cost of services, licenses and services (deprecated 2018-01-31) for the quarter ending 2018-12-31 was $2.44M, a 55.47% increase year-over-year.
- NATERA, INC. cost of services, licenses and services (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $2.20M, a 108.92% increase year-over-year.
- NATERA, INC. cost of services, licenses and services (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $1.79M, a 110.71% increase year-over-year.
- NATERA, INC. cost of services, licenses and services (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.54M, a 151.14% increase year-over-year.
- NATERA, INC. cost of services, licenses and services (deprecated 2018-01-31) for fiscal 2018 was $7.97M, a 95.06% increase from fiscal 2017.
- NATERA, INC. cost of services, licenses and services (deprecated 2018-01-31) for fiscal 2017 was $4.09M, a 278.52% increase from fiscal 2016.
- NATERA, INC. cost of services, licenses and services (deprecated 2018-01-31) for fiscal 2016 was $1.08M.
| Period end | Cost of Services, Licenses and Services (Deprecated 2018-01-31) 3 month | Cost of Services, Licenses and Services (Deprecated 2018-01-31) 6 month | Cost of Services, Licenses and Services (Deprecated 2018-01-31) 9 month | Cost of Services, Licenses and Services (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $2.44M 10-K · filed 2019-03-15 | $4.65M derived: sum of 2 quarters · filed 2019-03-15 | $6.44M derived: sum of 3 quarters · filed 2019-03-15 | $7.97M 10-K · filed 2019-03-15 |
| 2018-09-30 | $2.20M 10-K · filed 2019-03-15 | $3.99M derived: sum of 2 quarters · filed 2019-03-15 | $5.53M derived: sum of 3 quarters · filed 2019-03-15 | $7.10M derived: sum of 4 quarters · filed 2019-03-15 |
| 2018-06-30 | $1.79M 10-K · filed 2019-03-15 | $3.33M derived: sum of 2 quarters · filed 2019-03-15 | $4.90M derived: sum of 3 quarters · filed 2019-03-15 | $5.95M derived: sum of 4 quarters · filed 2019-03-15 |
| 2018-03-31 | $1.54M 10-K · filed 2019-03-15 | $3.11M derived: sum of 2 quarters · filed 2019-03-15 | $4.16M derived: sum of 3 quarters · filed 2019-03-15 | $5.01M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-12-31 | $1.57M 10-K · filed 2019-03-15 | $2.63M derived: sum of 2 quarters · filed 2019-03-15 | $3.48M derived: sum of 3 quarters · filed 2019-03-15 | $4.09M 10-K · filed 2019-03-15 |
| 2017-09-30 | $1.05M 10-K · filed 2019-03-15 | $1.90M derived: sum of 2 quarters · filed 2019-03-15 | $2.52M 10-Q · filed 2017-11-09 | $3.10M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $850.00K 10-K · filed 2019-03-15 | $1.46M 10-Q · filed 2017-08-09 | $2.04M derived: sum of 3 quarters · filed 2019-03-15 | $2.54M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $612.00K 10-K · filed 2019-03-15 | $1.19M derived: sum of 2 quarters · filed 2019-03-15 | $1.69M derived: sum of 3 quarters · filed 2019-03-15 | |
| 2016-12-31 | $580.00K 10-K · filed 2018-03-15 | $1.08M derived: sum of 2 quarters · filed 2018-03-15 | $1.08M 10-K · filed 2019-03-15 | |
| 2016-09-30 | $500.00K 10-K · filed 2018-03-15 | $500.00K 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |